You are here

AbbVie

AbbVie cuts Editas CRISPR pact it inherited from Allergan

AbbVie cuts Editas CRISPR pact it inherited from Allergan

Fierce Biotech

Editas Medicine

Flag link:

AbbVie cans Voyager Alzheimer’s, Parkinson’s gene therapy pacts

AbbVie cans Voyager Alzheimer’s, Parkinson’s gene therapy pacts

Fierce Biotech

Alzheimer's disease

Parkinson's Disease

Voyager Therapeutics

Flag link:

Platform study designed to rapidly screen potential Covid-19 drugs enrolls first patients

Platform study designed to rapidly screen potential Covid-19 drugs enrolls first patients

MedCity News

clinical trials

Flag link:

AbbVie shares rises on strong Q2, though cosmetic Botox sales tumbled 43%

AbbVie shares rises on strong Q2, though cosmetic Botox sales tumbled 43%

Marketwatch

Flag link:

AbbVie preps a challenge to a rival migraine drug from Biohaven, spelling out an upbeat set of PhIII data

AbbVie preps a challenge to a rival migraine drug from Biohaven, spelling out an upbeat set of PhIII data

Endpoints

Flag link:

How Abbvie Closed The Strategic Distance Of Its Remote Teams

How Abbvie Closed The Strategic Distance Of Its Remote Teams

Forbes

Flag link:

AbbVie, already famous for its Humira strategy, forms another 'patent wall' around Imbruvica: report

AbbVie, already famous for its Humira strategy, forms another 'patent wall' around Imbruvica: report

Fierce Pharma

Flag link:

AbbVie's Rinvoq Hits the Mark in Pivotal Phase III Dermatitis Trial

AbbVie's Rinvoq Hits the Mark in Pivotal Phase III Dermatitis Trial

BioSpace

atopic dermatitis

clinical trials

Flag link:

AbbVie's 'drip-feed' of patents shields top cancer drug from competition, group says

AbbVie's 'drip-feed' of patents shields top cancer drug from competition, group says

BioPharma Dive

Flag link:

AbbVie draws first blood in trade secrets war between Allergan's Botox and Evolus

AbbVie draws first blood in trade secrets war between Allergan's Botox and Evolus

Fierce Pharma

Daewoong Pharmaceuticals

Flag link:

Pfizer, Novartis and more halt July ads on Facebook to protest hate and racism

Pfizer, Novartis and more halt July ads on Facebook to protest hate and racism

Fierce Pharma

pharma advertising

Flag link:

Large UK study finds no benefit to HIV antiviral in COVID-19

Large UK study finds no benefit to HIV antiviral in COVID-19

BioPharma Dive

Flag link:

FDA rejects AbbVie's eye drug, citing safety concerns

FDA rejects AbbVie's eye drug, citing safety concerns

BioPharma Dive

Molecular Partners

wet age-related macular degeneration

Flag link:

Docs 'excited' to learn more about new migraine drugs from Biohaven, Lilly and AbbVie: analyst

Docs 'excited' to learn more about new migraine drugs from Biohaven, Lilly and AbbVie: analyst

Fierce Pharma

Flag link:

Sosei pens inflammatory and autoimmune disease drug pact with AbbVie

Sosei pens inflammatory and autoimmune disease drug pact with AbbVie

Fierce Biotech

Flag link:

Amid Allergan buyout, AbbVie dumps unwanted Assembly microbiome pact

Amid Allergan buyout, AbbVie dumps unwanted Assembly microbiome pact

Fierce Biotech

Assembly Biosciences

Flag link:

AbbVie beefs up the immunology pipeline, betting up to $865M on a PhII-ready drug — and fueling a biotech stock frenzy

AbbVie beefs up the immunology pipeline, betting up to $865M on a PhII-ready drug — and fueling a biotech stock frenzy

Endpoints

Alpine Immune Sciences

Flag link:

Abbvie-Allergan complete, but critics continue to raise anti-competitive concerns

Abbvie-Allergan complete, but critics continue to raise anti-competitive concerns

Endpoints

Flag link:

EHA: AbbVie, Roche cement Venclexta's place in AML with survival win

EHA: AbbVie, Roche cement Venclexta's place in AML with survival win

Fierce Pharma

Flag link:

AbbVie's Humira on Steroids (Literally) Treats Rheumatoid Arthritis Better Than the Original

AbbVie's Humira on Steroids (Literally) Treats Rheumatoid Arthritis Better Than the Original

Motley Fool

clinical trials

monoclonal antibodies

Flag link:

Pages